ICRF-187 as a cardioprotectant in children treated with anthracyclines

被引：3

作者：

Blatt, J

机构：

来源：

PEDIATRIC HEMATOLOGY AND ONCOLOGY | 1997年 / 14卷 / 03期

关键词：

anthracyclines; cardiotoxicity; childhood; ICRF-187;

D O I：

10.3109/08880019709009486

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：R3 / R6

页数：4

共 13 条

[1]

HERMAN EH, 1981, CANCER RES, V41, P3436

[2]

HERMAN EH, 1981, RES COMMUN CHEM PATH, V31, P85

[3]

HOLCENBERG JS, 1986, CANCER TREAT REP, V70, P703

[4] Dexrazoxane for protection against cardiotoxic effects of anthracyclines in children [J].

Lipshultz, SE .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :328-331

[5] THE DIOXOPIPERAZINE DERIVATIVES, THEIR LEUKEMOGENIC POTENTIAL AND OTHER BIOLOGICAL EFFECTS [J].

PEDERSENBJERGAARD, J .

LEUKEMIA RESEARCH, 1992, 16 (11) :1057-1059

[6] Use of ICRF-187 for prevention of anthracycline cardiotoxicity in children: Preliminary results [J].

Schiavetti, A ;

Castello, MA ;

Versacci, P ;

Varrasso, G ;

Padula, A ;

Ventriglia, F ;

Werner, B ;

Colloridi, V .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1997, 14 (03) :213-222

[7] PROTECTIVE EFFECT OF THE BISPIPERAZINEDIONE ICRF-187 AGAINST DOXORUBICIN-INDUCED CARDIAC TOXICITY IN WOMEN WITH ADVANCED BREAST-CANCER [J].

SPEYER, JL ;

GREEN, MD ;

KRAMER, E ;

REY, M ;

SANGER, J ;

WARD, C ;

DUBIN, N ;

FERRANS, V ;

STECY, P ;

ZELENIUCHJACQUOTTE, A ;

WERNZ, J ;

FEIT, F ;

SLATER, W ;

BLUM, R ;

MUGGIA, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (12) :745-752

[8]

TRUESDELL S, 1994, SURVIVORS CHILDHOOD, P159

[9]

VATS T, 1991, INVEST NEW DRUG, V9, P333

[10]

WADLER S, 1986, CANCER RES, V46, P1176

← 1 2 →